The company has an internationally leading testing platform and a strong technical team, committed to developing into a third medical laboratory in the field of special testing that has domestic advanced science and technology for the detection of neurological related diseases.

"Generally, the third laboratory adopts the outsourced CBA kit for testing. Due to the need for the preservation and validity of the kit, the fixed CBA (fixed CBA) test method is used. Due to the potential impact of cells on the production of antigen epitopes during the fixation process, the antigen may be in a natural state, which may have an impact on the accuracy of the test results.", "Making the fixed cell CBA method and the live cell CBA method produce more false positive results consistent with clinical practice is also lower than the live cell CBA method. For example, segment live cell CBA is still the standard for MOG-IgG antibody detection, and the commercial MOG-lgG kit method meets clinical needs.".